Cash flows from operating activities: | |
Net earnings | 16.28M |
Adjustments to reconcile net earnings to net cash provided by operating activities: | |
Depreciation and amortization | 13.64M |
Costs recognized on sale of acquired inventory | 4.22M |
Deferred income taxes | -1.17M |
Stock-based compensation expense | |
Excess tax benefit from stock option exercises | 253K |
Losses by equity method investees | |
Other | 262K |
Change in operating assets and liabilities, net of acquisitions: | |
Trade accounts and other receivables | -10.18M |
Inventories | -2.41M |
Prepaid expenses | 605K |
Trade, other accounts payable and accrued expenses | 4.13M |
Salaries, wages and related accruals | -7.26M |
Income taxes payable/receivable | |
Net cash provided by operating activities | |
Cash flows from investing activities: | |
Acquisitions, net of cash acquired | -259M |
Purchase of available-for-sale investments | |
Proceeds from maturities of available-for-sale investments | 0 |
Proceeds from sale of available-for-sale investments | |
Additions to property and equipment | -2.44M |
Distribution from unconsolidated entity | |
Increase in other long-term assets | |
Net cash (used in) provided by investing activities | |
Cash flows from financing activities: | |
Cash dividends | -11.93M |
Proceeds from stock option exercises | 2.03M |
Excess tax benefit from stock option exercises | |
Purchase of common stock for stock bonus plans | |
Repurchase of common stock | |
Net cash used in financing activities | |
Effect of exchange rate changes on cash and cash equivalents | 5.25M |
Net change in cash and cash equivalents | 5.35M |
Cash and cash equivalents at beginning of year | 64.24M |
Cash and cash equivalents at end of year | 69.59M |